22 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested … , and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption
8-K
EX-1.1
qioa82k4p rw
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
0qxmtr
1 Jul 22
Shelf registration
4:36pm
10-K
4a3x10 a7y79mswcs
14 Mar 22
Annual report
7:04am
10-Q
q521ka 8kb0fqkn
12 Aug 21
Quarterly report
8:53am
424B4
1n3lc99leur4gz nu33
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-1.1
fentoqw26sf
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
v9cmwom9j8xofrltg
14 Jun 21
IPO registration (amended)
6:15am